Oruka Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Oruka Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Oruka Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $12K, a 33.3% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $12K -$6K -33.3% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $12K -$6K -33.3% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $12K -$6K -33.3% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $12K -$6K -33.3% Sep 30, 2023 10-Q 2023-10-18
Q2 2023 $18K $0 0% Jun 30, 2023 10-Q 2023-07-21
Q1 2023 $18K $0 0% Mar 31, 2023 10-Q 2023-04-24
Q4 2022 $18K $0 0% Dec 31, 2022 10-K 2024-02-01
Q3 2022 $18K $0 0% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $18K $0 0% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $18K +$6K +50% Mar 31, 2022 10-Q 2022-05-02
Q4 2021 $18K +$6K +50% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $18K -$18K -50% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $18K -$6K -25% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $12K -$12K -50% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $12K -$12K -50% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $36K +$12K +50% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $24K $0 0% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $24K $0 0% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $24K $0 0% Dec 31, 2019 10-K 2021-03-18
Q3 2019 $24K $0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $24K $0 0% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $24K $0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $24K $0 0% Dec 31, 2018 10-K 2020-02-18
Q3 2018 $24K -$473K -95.2% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $24K -$563K -95.9% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $24K -$652K -96.5% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $24K -$742K -96.9% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $497K -$358K -41.9% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $587K -$229K -28.1% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $676K +$96K +16.6% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $766K +$136K +21.6% Dec 31, 2016 10-K 2018-03-22
Q3 2016 $855K +$176K +25.9% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $816K +$62K +8.22% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $580K +$27K +4.88% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 $630K +$22K +3.62% Dec 31, 2015 10-K 2017-03-21
Q3 2015 $679K +$131K +23.9% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $754K -$77K -9.27% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 $553K -$275K -33.2% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $608K +$478K +368% Dec 31, 2014 10-K 2016-03-17
Q3 2014 $548K +$448K +448% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $831K +$727K +699% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 $828K +$704K +568% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 $130K -$14K -9.72% Dec 31, 2013 10-K 2015-03-19
Q3 2013 $100K -$64K -39% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $104K -$79K -43.2% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 $124K -$80K -39.2% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 $144K -$80K -35.7% Dec 31, 2012 10-K 2014-03-20
Q3 2012 $164K -$80K -32.8% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $183K -$81K -30.7% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 $204K Mar 31, 2012 10-Q 2012-05-14
Q4 2011 $224K -$80K -26.3% Dec 31, 2011 10-K 2013-03-21
Q3 2011 $244K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $264K Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $304K Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.